Advertisement

Psychiatry General

Bipolar Disorder and Comorbid Use of Illicit Substances.

Nov 29, 2021

Substance use disorders (SUD) are highly prevalent in bipolar disorder (BD) and significantly affect clinical outcomes. Incidence and management of illicit drug use differ from alcohol use disorders, ...

Use of Valproate in Women: An Audit of Prescriptions to 10,001 Psychiatry, Neurology, and Neurosurgery Outpatients.

Nov 29, 2021

Gestational exposure to valproate is associated with an unacceptably high risk of major congenital malformations, neurodevelopmental disorders, and other adverse outcomes. Prescription of valproate t...

A novel event-related fMRI supervoxels-based representation and its application to schizophrenia diagnosis.

Nov 22, 2021

The schizophrenia diagnosis represents a difficult task because of the confusing descriptions of symptoms given by the patient, their similarity among several disorders, the lower familiarity with gen...

Are short AUDIT screeners effective in identifying unhealthy drinking of varying severity? A prison population study.

Nov 22, 2021

Whether brief versions of the Alcohol Use Disorder Identification Test (AUDIT) can be used as graded severity measures is largely unknown. We examined the performance of eight such brief screeners in ...

Effects of animal-assisted interventions for people with dementia: A systematic review and meta-analysis.

Nov 22, 2021

Animal-assisted interventions (AAIs) are non-pharmacological, cost-effective interventions developed to improve outcomes in patients with dementia; however, the effects remain inconclusive. The purpos...

Cariprazine-induced mania: a case-series report.

Nov 22, 2021

Bipolar depression is the most prevalent phase of bipolar disorder (BD). There is a risk of inducing treatment-emergent affective switches (TEAS) with antidepressants (ADs). Hence, clinical guidelines...

Does metabolic syndrome or its component factors alter the course of bipolar disorder? A systematic review.

Nov 22, 2021

Metabolic syndrome (MetS) and its component factors, obesity, hypertension, dyslipidaemia and insulin resistance, have shown a bidirectional relationship with the prevalence and severity of bipolar di...

Personalizing rTMS parameters for depression treatment using multimodal neuroimaging.

Nov 22, 2021

Repetitive transcranial magnetic stimulation (rTMS) is a tool that can be used to administer treatment to neuropsychiatric disorders such as major depressive disorder (MDD). Though, the clinical effic...

The Development of Somatic Symptom Disorder in Children: Psychological Characteristics and Psychiatric Comorbidity.

Nov 22, 2021

Somatic symptom disorder (SSD) is one of the most common pediatric psychiatric disorders in adolescents, and several biological, psychological, and social factors have been considered to contribute to...

Sleep disturbances, fatigue and psychological health in women with endometriosis: a matched pair case-control study.

Nov 15, 2021

What are the associations between endometriosis, pelvic pain symptoms, fatigue and sleep? Psychological health and quality of life in endometriosis patients with good versus bad quality of sleep were ...

The Immune-Kynurenine Pathway in Social Anxiety Disorder.

Nov 15, 2021

The tryptophan-kynurenine pathway is of major interest in psychiatry and is altered in patients with depression, schizophrenia and panic disorder. Stress and immune alterations can impact this system,...

Neural autoantibodies in delirium.

Nov 15, 2021

Delirium in hospitalized and intensive care unit patients is an emerging condition due to its rapid-onset requiring fast action to mitigate a worse clinical outcome. Although several causes and condit...

What not to use in bipolar disorders: a systematic review of non-recommended treatments in clinical practice guidelines.

Nov 15, 2021

Clinical practice guidelines (CPG) are an important tool for implementation of evidence-based clinical care. Despite clinical trials showing lack of efficacy of some agents in bipolar disorder (BD), t...

[Clinical characteristics, surgical treatment and prognosis of rolandic and perirolandic drug-resistant epilepsies].

Nov 15, 2021

To explore the clinical characteristics, treatment strategies and prognosis of rolandic and perirolandic drug-resistant epilepsies (DREs). The clinical data of 53 patients diagnosed with rolandic or...

Multi-omics of human plasma reveals molecular features of dysregulated inflammation and accelerated aging in schizophrenia.

Nov 08, 2021

Schizophrenia is a devastating psychiatric illness that detrimentally affects a significant portion of the worldwide population. Aging of schizophrenia patients is associated with reduced longevity, b...

Ouabain inhibitor rostafuroxin attenuates dextromethorphan-induced manic potential.

Nov 08, 2021

Dextromethorphan (DM) abuse produces mania-like symptoms in humans. ERK/Akt signaling activation involved in manic potential can be attenuated by the inhibition of ouabain-like cardiac steroids. In th...

Exploration of the anti-insomnia mechanism of Ganoderma by central-peripheral multi-level interaction network analysis.

Nov 01, 2021

Ganoderma (Lingzhi in Chinese) has shown good clinical outcomes in the treatment of insomnia, restlessness, and palpitation. However, the mechanism by which Ganoderma ameliorates insomnia is unclear. ...

Trends in big data analyses by multicenter collaborative translational research in psychiatry.

Nov 01, 2021

The underlying pathologies of psychiatric disorders, which cause substantial personal and social losses, remain unknown, and their elucidation is an urgent issue. To clarify the core pathological mech...

Plasma fatty acid-binding protein 7 concentration correlates with depression/anxiety, cognition, and positive symptom in patients with schizophrenia.

Nov 01, 2021

Because of the involvement of the brain in the pathophysiology of psychiatric disorders, obtaining information on the biochemical features that directly contribute to symptoms is challenging. The pres...

Selective serotonin reuptake inhibitors and manic switch: A pharmacovigilance and pharmacodynamical study.

Nov 01, 2021

There is still no approved mechanism of manic switch in bipolar disorder, yet many selective serotonin reuptake inhibitors were accused for this important adverse event. Therefore, we aimed to investi...

SUBSPECIALTIES

Advertisement